Over The Counter 1 Feb 2023: Biotech Is Solving Beauty’s Eco Challenges, Elevating R&D, With Amyris’ Annie Tsong
Executive Summary
In this "Over the Counter" episode, HBW Insight chats with Annie Tsong, chief strategy and product officer at Amyris, Inc., an Emeryville, Calif.-based company that uses synthetic biotechnology to produce clean beauty, personal care, wellness and food ingredients for thousands of brands across the globe, including its own. Leading the firm’s ingredient development pipeline, Tsong discusses the science as well as the benefits of biotech alternatives to traditional beauty ingredients – including sustainability and better performance – and reflects on how the science is already transforming the beauty landscape.
You may also be interested in...
FDA’s OTC Monograph User Fees Are Existential Threat To Small Contract Manufacturers, Cosmetics Brands
OMUFA reauthorization should include small business considerations for the US FDA’s OTC Monograph Drug User Fee Program, which established in 2020 a ‘one-size-fits-all’ facility and monograph order request user fee system which could lead to more contract manufacturer exits, a manufacturing bottleneck for OTC cosmetic products, and fewer product choices, says IBA.
US FTC Says It’s On ‘Solid Ground’ To Bring Cases Following Notices Of Penalty Offense
The US Federal Trade Commission is "fully prepared" to bring forward cases after issuing hundreds of penalty offense notices in April regarding health claims substantiation, and it is likely to seek injunctive and monetary relief, said Samuel Levine, director of the FTC’s Bureau of Consumer Protection, at the National Advertising Division’s annual conference in Philadelphia.
FTC On AI And Consumer Vulnerabilities: ‘One Self-Regulatory Failure Is Begetting Another’
The US FTC’s Sam Levine, director of the Bureau of Consumer Protection, discusses the advent of AI and the compounding risks consumers face in today’s evolving, largely unregulated, profoundly uncertain digital age.